[Viva] Fwd: IAS Calls For Nominations For HIV Cure Initiative Community Representatives

[Margarite Sanchez]

fyi ....

---------- Forwarded message ----------
From: GnPPlus <communications at gnpplus.net>
Date: Mon, Sep 30, 2013 at 3:13 AM
Subject: IAS Calls For Nominations For HIV Cure Initiative Community
Representatives
To: margaritesanchez at gmail.com



The International AIDS Society (IAS) has announced it is receiving
Community Representatives nominations for its HIV Cure Initiative.

*Background*

Under the auspices of the IAS, a group of more than 30 scientists
developed a Global Scientific Strategy: Towards an HIV Cure. The IAS
launched the Global Scientific Strategy at a scientific symposium,
immediately preceding the XIX International AIDS Conference in
Washington, DC in July 2012, with the support of the NIH, the ANRS,
Sidaction and TAG. The symposium was structured in line with the
scientific priorities defined in the Global Scientific Strategy.

The IAS and the Towards an HIV Cure Stakeholder’s Advisory Board are
now fully dedicated to ensuring significant roll-out of the Global
Scientific Strategy and plan to coordinate future developments in
collaborations and in advocating the benefits of an HIV cure.
Following the seminal work of the International Scientific Working
Group in the establishment of the Global Scientific Strategy, the IAS
has facilitated the creation of a number of smaller topic specific
working groups.

These working groups bring together leading scientists and community
members to work on relevant topics, including ethics, psycho-social
studies, public health and cost-effectiveness as detailed below.
Moreover the IAS has also mediated the creation of an Industry
Collaboration Group with the aim to bring together industry partners
and cure researchers to facilitate and encourage interactions and
collaborations. In

addition, the IAS is planning to organize symposia, workshops and
training sessions in conjunction with international, regional and
national conferences both for health care providers and community
members.

The aim of the initiative is to contribute both to maximizing
resources and strategic investment in the most promising strategies in
search of a cure, and to the establishment of an international
research alliance and/or expansion and global collaboration of
existing consortia.

The Towards an HIV Cure initiative is committed to recruiting and
sustaining skilled, effective, diverse and gender-balanced working
groups, and to the greater involvement of PLHIV. The HIV Cure
initiative is requesting nominations from PLHIV for participation in
the following working groups and to facilitate trainings.

*Working Group on Cost-Effectiveness*

The Working Group on Cost-Effectiveness will prepare an opinion piece
on the cost-effectiveness of different potential HIV cure strategies
in 2013. The group will also determine the HIV cure strategies which
should be assessed in mathematical models for cost-effectiveness in
order to develop short-term affordable strategies to cure HIV
considering the long-term toxicity of ART and the difficulty of
life-long adherence.

The working group will also calculate an estimate of the global cost
of the Global Scientific Strategy: Towards an HIV Cure.

The Working Group on Cost-Effectiveness may meet periodically by
conference call to review ongoing activities and bi-annually for
in-person meetings typically in conjunction with the Conference on
Retroviruses and Opportunistic Infections (CROI: February/March) and
IAS/AIDS Conferences (July).

*Industry Collaboration Group*

The Industry Collaboration Group aims to bring together industry
partners and cure researchers to facilitate and encourage interactions
and collaborations. The Industry Collaboration Group is co-chaired by
two scientists (David Margolis, UNC and Sharon Lewin, The Burnet
Institute, Melbourne) and two industry representatives (Andrew
Spaltenstein, GSK and Guenter Kraus, Janssen) and the aim of the group
is to foster the involvement of industry to develop a safe, accessible
and scalable cure for HIV.

The Industry Collaboration Group may meet periodically by conference
call to review ongoing activities and bi-annually for in-person
meetings typically in conjunction with the Conference on Retroviruses
and Opportunistic Infections (CROI: February/March) and IAS/AIDS
Conferences (July).

*Psychosocial Studies Group*

The Psychosocial Studies Group consists of a multinational academic
and community-based research team developing a multi-country project
to assess the willingness of patients to participate in HIV-cure
related strategies and the potential impact of an HIV cure from a
social and behavioral sciences perspective.

The Psychosocial Studies Group may meet periodically by conference
call to review ongoing activities and bi-annually for in-person
meetings typically in conjunction with International Conferences and
Social Science Conferences.
*Eligibility Criteria*

Preference will be given to candidates who meet the following
eligibility criteria:

 Affiliation with an organization involved in HIV-related issues

 Familiarity with and understanding of current HIV-cure research and
strategies

 Ability to disseminate information about the cure initiative to other
community

 contacts

 Willing to serve in a voluntary capacity, without remuneration.
Travel support to Working Group meetings may be provided.

*Nomination Process*:

Nominations must be made in writing and must include the curriculum
vitae of the nominee, along with a letter of intent describing how the
candidate meets the eligibility requirements as outlined above, and
which working group they would like to participate in. Please submit
applications by email to hivcure at iasociety.org no later than 30
September 2013.

Please include the following information in the email:

Nominee Name

Mailing Address

Email Address

Current Employment

Note: applications that do not include a nominee’s curriculum vitae
and letter of intent will not be considered.

The review process will be coordinated by IAS staff under the guidance
of members of the Towards an HIV Cure Stakeholder’s Advisory Board.



--
If you do not want to receive any more newsletters,
http://www.gnpplus.net/newsletters/?p=unsubscribe&uid=1c77fd15c9e3023361f36e7b427b3679

To update your preferences and to unsubscribe visit
http://www.gnpplus.net/newsletters/?p=preferences&uid=1c77fd15c9e3023361f36e7b427b3679
Forward a Message to Someone
http://www.gnpplus.net/newsletters/?p=forward&uid=1c77fd15c9e3023361f36e7b427b3679&mid=152


--
Powered by PHPlist, www.phplist.com --
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.resist.ca/pipermail/viva/attachments/20131005/568c306c/attachment.html>